1. Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC et al. Colorectal cancer statistics, 2020. CA Cancer J Clin 2020. doi: [10.3322/caac.21601]
2. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-535. doi:
3. Ullman T, Odze R, Farraye FA. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflammatory bowel diseases 2009; 15: 630-638. doi: [10.1002/ibd.20766]
4. Hao XP, Frayling IM, Sgouros JG, Du MQ, Willcocks TC, Talbot IC et al. The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomas. Gut 2002; 50: 834-839. doi:
5. Tarmin L, Yin J, Harpaz N, Kozam M, Noordzij J, Antonio LB et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer research 1995; 55: 2035-2038. doi:
6. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabinovitch PS. c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 1990; 99: 416-420. doi:
7. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel J-F. Ulcerative colitis. Lancet (London, England) 2017; 389: 1756-1770. doi: [10.1016/S0140-6736(16)32126-2]
8. Castaño-Milla C, Chaparro M, Gisbert JP. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Alimentary pharmacology & therapeutics 2014; 39: 645-659. doi:
9. Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature 2013; 501: 328-337. doi: [10.1038/nature12624]
10. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009; 458: 719-724. doi: [10.1038/nature07943]
11. Tanay A, Regev A. Scaling single-cell genomics from phenomenology to mechanism. Nature 2017; 541: 331-338. doi: [10.1038/nature21350]
12. Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science (New York, N.Y.) 2016; 352: 189-196. doi: [10.1126/science.aad0501]
13. Ni X, Zhuo M, Su Z, Duan J, Gao Y, Wang Z et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proceedings of the National Academy of Sciences of the United States of America 2013; 110: 21083-21088. doi: [10.1073/pnas.1320659110]
14. Kim K-T, Lee HW, Lee H-O, Kim SC, Seo YJ, Chung W et al. Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells. Genome biology 2015; 16: 127. doi: [10.1186/s13059-015-0692-3]
15. Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer cell 2004; 6: 447-458. doi:
16. Aibar S, González-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G et al. SCENIC: single-cell regulatory network inference and clustering. Nature methods 2017; 14: 1083-1086. doi: [10.1038/nmeth.4463]
17. He Q, Zhao L, Liu Y, Liu X, Zheng J, Yu H et al. circ-SHKBP1 Regulates the Angiogenesis of U87 Glioma-Exposed Endothelial Cells through miR-544a/FOXP1 and miR-379/FOXP2 Pathways. Molecular therapy. Nucleic acids 2018; 10: 331-348. doi: [10.1016/j.omtn.2017.12.014]
18. Chen J, Fu Y, Day DS, Sun Y, Wang S, Liang X et al. VEGF amplifies transcription through ETS1 acetylation to enable angiogenesis. Nature communications 2017; 8: 383. doi: [10.1038/s41467-017-00405-x]
19. Bahrami A, Amerizadeh F, ShahidSales S, Khazaei M, Ghayour-Mobarhan M, Sadeghnia HR et al. Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress. Journal of cellular biochemistry 2017; 118: 1979-1983. doi: [10.1002/jcb.25903]
20. Kim S-H, Park Y-Y, Cho S-N, Margalit O, Wang D, DuBois RN. Krüppel-Like Factor 12 Promotes Colorectal Cancer Growth through Early Growth Response Protein 1. PloS one 2016; 11: e0159899. doi: [10.1371/journal.pone.0159899]
21. O'Connell JT, Sugimoto H, Cooke VG, MacDonald BA, Mehta AI, LeBleu VS et al. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proceedings of the National Academy of Sciences of the United States of America 2011; 108: 16002-16007. doi: [10.1073/pnas.1109493108]
22. Fang M, Yuan J, Peng C, Li Y. Collagen as a double-edged sword in tumor progression. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014; 35: 2871-2882. doi: [10.1007/s13277-013-1511-7]
23. Cirri P, Chiarugi P. Cancer associated fibroblasts: the dark side of the coin. American journal of cancer research 2011; 1: 482-497. doi:
24. Silver DJ, Siebzehnrubl FA, Schildts MJ, Yachnis AT, Smith GM, Smith AA et al. Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment. The Journal of neuroscience : the official journal of the Society for Neuroscience 2013; 33: 15603-15617. doi: [10.1523/JNEUROSCI.3004-12.2013]
25. Yopp AC, Shia J, Butte JM, Allen PJ, Fong Y, Jarnagin WR et al. CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases. Annals of surgical oncology 2012; 19 Suppl 3: S339-S346. doi: [10.1245/s10434-011-1774-4]
26. Fearon DT. The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance. Cancer immunology research 2014; 2: 187-193. doi: [10.1158/2326-6066.CIR-14-0002]
27. Voutsadakis IA. Peroxisome proliferator-activated receptor gamma (PPARgamma) and colorectal carcinogenesis. Journal of cancer research and clinical oncology 2007; 133: 917-928. doi:
28. Yun S-H, Roh M-S, Jeong J-S, Park J-I. Peroxisome proliferator-activated receptor γ coactivator-1α is a predictor of lymph node metastasis and poor prognosis in human colorectal cancer. Annals of diagnostic pathology 2018; 33: 11-16. doi: [10.1016/j.anndiagpath.2017.11.007]
29. Almatov KT, Agzamov K, Rakhimov MM. [Oxidative phosphorylation in mitochondria from digestive organs in chronic allergic colitis]. Voprosy meditsinskoi khimii 1982; 28: 44-49. doi:
30. Lampert F, Stafa D, Goga A, Soste MV, Gilberto S, Olieric N et al. The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation. eLife 2018; 7. doi: [10.7554/eLife.35528]
31. Wang CY, Bassuk AG, Boise LH, Thompson CB, Bravo R, Leiden JM. Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors. Molecular and cellular biology 1994; 14: 1153-1159. doi:
32. Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, Froelich CJ et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (New York, N.Y.) 1998; 282: 121-125. doi:
33. Kuranaga Y, Sugito N, Shinohara H, Tsujino T, Taniguchi K, Komura K et al. SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells. International journal of molecular sciences 2018; 19. doi: [10.3390/ijms19103012]
34. Huang Y-H, Zhu C, Kondo Y, Anderson AC, Gandhi A, Russell A et al. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature 2015; 517: 386-390. doi: [10.1038/nature13848]
35. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nature reviews. Cancer 2012; 12: 252-264. doi: [10.1038/nrc3239]
36. Miele A, Medina R, van Wijnen AJ, Stein GS, Stein JL. The interactome of the histone gene regulatory factor HiNF-P suggests novel cell cycle related roles in transcriptional control and RNA processing. Journal of cellular biochemistry 2007; 102: 136-148. doi:
37. Campisi J, Gray HE, Pardee AB, Dean M, Sonenshein GE. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell 1984; 36: 241-247. doi:
38. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. The Journal of clinical investigation 2009; 119: 1420-1428. doi: [10.1172/JCI39104]
39. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411: 366-374. doi:
40. Zheng J, He S, Qi J, Wang X, Yu J, Wu Y et al. Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo. International journal of oncology 2017; 51: 478-488. doi: [10.3892/ijo.2017.4040]
41. Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N et al. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. The New England journal of medicine 2016; 374: 211-222. doi: [10.1056/NEJMoa1506597]
42. Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R et al. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut 2010; 59: 227-235. doi: [10.1136/gut.2009.184176]
43. Greaves M, Maley CC. Clonal evolution in cancer. Nature 2012; 481: 306-313. doi: [10.1038/nature10762]
44. Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nature biotechnology 2014; 32: 381-386. doi: [10.1038/nbt.2859]
45. Claesson L, Larhammar D, Rask L, Peterson PA. cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure. Proceedings of the National Academy of Sciences of the United States of America 1983; 80: 7395-7399. doi:
46. Ghoochani A, Schwarz MA, Yakubov E, Engelhorn T, Doerfler A, Buchfelder M et al. MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis. Oncogene 2016; 35: 6246-6261. doi: [10.1038/onc.2016.160]
47. Murayama T, Nakaoku T, Enari M, Nishimura T, Tominaga K, Nakata A et al. Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit. Cancer research 2016; 76: 974-983. doi: [10.1158/0008-5472.CAN-15-2135]
48. Bozzi F, Mogavero A, Varinelli L, Belfiore A, Manenti G, Caccia C et al. MIF/CD74 axis is a target for novel therapies in colon carcinomatosis. Journal of experimental & clinical cancer research : CR 2017; 36: 16. doi: [10.1186/s13046-016-0475-z]
49. Gruber AD, Elble RC, Ji HL, Schreur KD, Fuller CM, Pauli BU. Genomic cloning, molecular characterization, and functional analysis of human CLCA1, the first human member of the family of Ca2+-activated Cl- channel proteins. Genomics 1998; 54: 200-214. doi:
50. Toda M, Tulic MK, Levitt RC, Hamid Q. A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. The Journal of allergy and clinical immunology 2002; 109: 246-250. doi:
51. Bustin SA, Li SR, Dorudi S. Expression of the Ca2+-activated chloride channel genes CLCA1 and CLCA2 is downregulated in human colorectal cancer. DNA and cell biology 2001; 20: 331-338. doi:
52. Yang B, Cao L, Liu J, Xu Y, Milne G, Chan W et al. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer. Cancer 2015; 121: 1570-1580. doi: [10.1002/cncr.29235]
53. Nakagawa H, Inazawa J, Inoue K, Misawa S, Kashima K, Adachi H et al. Assignment of the human renal dipeptidase gene (DPEP1) to band q24 of chromosome 16. Cytogenetics and cell genetics 1992; 59: 258-260. doi:
54. McIver CM, Lloyd JM, Hewett PJ, Hardingham JE. Dipeptidase 1: a candidate tumor-specific molecular marker in colorectal carcinoma. Cancer letters 2004; 209: 67-74. doi:
55. Ziegenhain C, Vieth B, Parekh S, Reinius B, Guillaumet-Adkins A, Smets M et al. Comparative Analysis of Single-Cell RNA Sequencing Methods. Molecular cell 2017; 65. doi: [10.1016/j.molcel.2017.01.023]
56. Haque A, Engel J, Teichmann SA, Lönnberg T. A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications. Genome medicine 2017; 9: 75. doi: [10.1186/s13073-017-0467-4]
57. Young MD, Mitchell TJ, Vieira Braga FA, Tran MGB, Stewart BJ, Ferdinand JR et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science (New York, N.Y.) 2018; 361: 594-599. doi: [10.1126/science.aat1699]
58. Song M, Willett WC, Hu FB, Spiegelman D, Must A, Wu K et al. Trajectory of body shape across the lifespan and cancer risk. International journal of cancer 2016; 138: 2383-2395. doi: [10.1002/ijc.29981]
59. Hirsch D, Wangsa D, Zhu YJ, Hu Y, Edelman DC, Meltzer PS et al. Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis. Clinical cancer research : an official journal of the American Association for Cancer Research 2018; 24: 4997-5011. doi: [10.1158/1078-0432.CCR-18-0630]